-
Bee yoga: Inside an unusual wellness experience in south-west France
'It’s about creating a connection with bees and learning to communicate with them'
-
Man dies after contracting Shamonda virus in France
Case is world-first for transmission of illness to humans
-
Doctors and dentists in France face action after failing to show fees
Nearly 40% of private healthcare providers investigated broke rules; how to avoid it happening to you
France to give third Covid vaccine dose to those with immunodeficiency
The extra dose will be available for people on dialysis and people who have had organ transplants, among others
France has approved giving a third dose of a Covid-19 vaccine to certain patients who are “severely immunocompromised”.
This covers patients who have had organ transplants, recent bone marrow transplant patients, patients on dialysis, and patients with autoimmune diseases undergoing strong immunosuppressive treatment such as anti-CD20 or antimetabolites.
The decision was announced by the Direction générale de la Santé (DGS), an arm of the French health ministry, on April 11.
The patients who are eligible for the third dose will receive either the Pfizer-BioNTech or Moderna vaccine.
They should receive the third dose four weeks after the second, or as soon as possible if it has already been more than four weeks since their second dose.
The DGS stated that this schedule could be extended at a later date to include non-dialysis chronic kidney disease patients, cancer patients and autoimmune disease patients on other immunosuppressive treatments.
It also said that family members, those living under the same roof and carers of people suffering from severe immunocompromisation should become eligible for a Covid-19 vaccination “in the near future”, if they are not already due to their age and/or health.
Read more:
Do I still need a vaccination after I have had Covid-19?
How will suspension of Johnson & Johnson Covid vaccine impact France?
